Back to search

Spain· ES:1262028001

MCOMBRIAX DISPERSION INYECTABLE EN JERINGA PRECARGADA

A medicinal product containing vacuna anti gripal arnm + vacuna anti covid-19 (moderna) arnm para xbb.1.5 (provisional), registered in Spain by Moderna Biotech Spain S.L..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedMCOMBRIAX DISPERSION INYECTABLE EN JE…ATC—REGISTER NO.ES:1262028001PACKS LISTED0CHECKEDJune 3, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
vacuna anti gripal ARNm + vacuna anti COVID-19 (Moderna) ARNm para XBB.1.5 (provisional)
Manufacturer
Moderna Biotech Spain S.L.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
June 3, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1f976b14-f34d-43b0-9642-67d3f2f6f71f
GET /v1/drugs/1f976b14-f34d-43b0-9642-67d3f2f6f71f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1777471380000}",
  "nregistro": "1262028001",
  "substance": "vacuna anti gripal ARNm + vacuna anti COVID-19 (Moderna) ARNm para XBB.1.5 (provisional)"
}

See everything about vacuna anti gripal arnm + vacuna anti covid-19 (moderna) arnm para xbb.1.5 (provisional).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.